Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Graef

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Rheumatology and Immunology Research|March 7, 2023
Social Media for Research Discourse, Dissemination, and Collaboration in RheumatologyAriella Coler-Reilly, Elizabeth R Graef, Alfred H J Kim, et al.
Annals of the Rheumatic Diseases|May 9, 2020
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19Maximilian F Konig, Alfred Hj Kim, Marc H Scheetz, et al.
The Journal of Rheumatology|August 1, 2025
Engaging Arabic-Speaking Patients With Rheumatic Diseases Through Social Media: A Multinational Infodemiology AnalysisIhsane Hmamouchi, Jean W Liew, Nelly Ziade, et al.
Annals of Internal Medicine|April 1, 2020
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19Alfred H J Kim, Jeffrey A Sparks, Jean W Liew, et al.
Expert Review of Clinical Immunology|July 5, 2020
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19Sebastian E Sattui, Jean W Liew, Elizabeth R Graef, et al.
Annals of the Rheumatic Diseases|April 17, 2020
<i>Festina lente</i>: hydroxychloroquine, COVID-19 and the role of the rheumatologistElizabeth R Graef, Jean W Liew, Michael S Putman, et al.
Seminars in Arthritis and Rheumatism|September 15, 2020
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping reviewAdam Kilian, Yu Pei Chock, Irvin J Huang, et al.
ACR Open Rheumatology|August 24, 2022
Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported RegistryKanon Jatuworapruk, Anna Montgomery, Milena Gianfrancesco, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2021
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-AnalysisRichard Conway, Alyssa A Grimshaw, Maximilian F Konig, et al.
RMD Open|September 14, 2022
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveyMichael DiIorio, Kevin Kennedy, Jean W Liew, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Rheumatology and Immunology Research|March 7, 2023
Social Media for Research Discourse, Dissemination, and Collaboration in RheumatologyAriella Coler-Reilly, Elizabeth R Graef, Alfred H J Kim, et al.
Annals of the Rheumatic Diseases|May 9, 2020
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19Maximilian F Konig, Alfred Hj Kim, Marc H Scheetz, et al.
The Journal of Rheumatology|August 1, 2025
Engaging Arabic-Speaking Patients With Rheumatic Diseases Through Social Media: A Multinational Infodemiology AnalysisIhsane Hmamouchi, Jean W Liew, Nelly Ziade, et al.
Annals of Internal Medicine|April 1, 2020
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19Alfred H J Kim, Jeffrey A Sparks, Jean W Liew, et al.
Expert Review of Clinical Immunology|July 5, 2020
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19Sebastian E Sattui, Jean W Liew, Elizabeth R Graef, et al.
Annals of the Rheumatic Diseases|April 17, 2020
<i>Festina lente</i>: hydroxychloroquine, COVID-19 and the role of the rheumatologistElizabeth R Graef, Jean W Liew, Michael S Putman, et al.
Seminars in Arthritis and Rheumatism|September 15, 2020
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping reviewAdam Kilian, Yu Pei Chock, Irvin J Huang, et al.
ACR Open Rheumatology|August 24, 2022
Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported RegistryKanon Jatuworapruk, Anna Montgomery, Milena Gianfrancesco, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 22, 2021
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-AnalysisRichard Conway, Alyssa A Grimshaw, Maximilian F Konig, et al.
RMD Open|September 14, 2022
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveyMichael DiIorio, Kevin Kennedy, Jean W Liew, et al.
Pageof 2